Report Overview
The Global Veterinary Antiparasitics Market size is expected to be worth around US$ 14.2 Billion by 2035 from US$ 6.9 Billion in 2025, growing at a Veterinary Antiparasitics Market during the forecast period 2026-2035. In 2025, North America led the market, achieving over 38.6% share with a revenue of US$ 2.7 Billion.
Veterinary antiparasitics are medicines used to prevent, control, and eliminate internal and external parasites that affect livestock, companion animals, and other species. These products play a vital role in maintaining animal health, improving productivity, and reducing the economic burden associated with parasitic infections.
Internal parasites, such as roundworms, tapeworms, and flukes, can impair growth, reduce feed efficiency, and weaken immunity. External parasites, including ticks, fleas, lice, and mites, can cause discomfort, skin disorders, blood loss, and transmission of serious diseases. Veterinary antiparasitic products are specifically formulated to target these parasites while ensuring animal safety when used according to recommended guidelines.
The market offers a wide range of antiparasitic solutions, including oral tablets, injectables, pour-on formulations, spot-on treatments, sprays, and medicated feed additives. Common active ingredients include ivermectin, moxidectin, praziquantel, fipronil, and other advanced compounds designed to provide broad-spectrum protection.
Growing awareness of animal welfare, increasing pet ownership, and the expansion of commercial livestock production are driving demand for effective parasite control programs. In addition, ongoing research and development efforts are leading to innovative products with improved efficacy, safety profiles, and ease of administration.
As parasite resistance remains a global concern, veterinarians emphasize the importance of responsible product use, regular monitoring, and integrated parasite management strategies to ensure long-term effectiveness and sustainable animal health outcomes.
Click here for more information: https://market.us/report/veterinary-antiparasitics-market/
Key Takeaways
In 2025, the market generated a revenue of US$ 6.9 Billion, with a CAGR of 7.5%, and is expected to reach US$ 14.2 Billion by the year 2035.
The product type segment is divided into ectoparasiticides, endoparasiticides, endectocides and others, with ectoparasiticides taking the lead with a market share of 42.6%.
Considering animal type, the market is divided into companion animals and livestock animals. Among these, companion animals held a significant share of 64.8%.
Furthermore, concerning the route of administration segment, the market is segregated into oral, injectable and topical. The oral sector stands out as the dominant player, holding the largest revenue share of 44.6% in the market.
The end-user segment is segregated into veterinary hospitals and clinics, animal farms and home care settings, with the veterinary hospitals and clinics segment leading the market, holding a revenue share of 64.0%.
North America led the market by securing a market share of 38.6%.
Key Market Segments
By Product Type
Ectoparasiticides
Endoparasiticides
Endectocides
Others
By Animal Type
Companion Animals
Livestock Animals
By Route of Administration
Oral
Injectable
Topical
By End-User
Veterinary Hospitals and Clinics
Animal Farms
Home Care Settings
Top Key Players
Zoetis Inc.
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Virbac
Ceva Santé Animale
Dechra Pharmaceuticals PLC
Vetoquinol S.A.
Norbrook Laboratories Ltd.
Animalcare Group plc
Biogénesis Bagó
Petmedica
Emerging Trends in Veterinary Antiparasitics
Rising Focus on Antiparasitic Resistance: Antiparasitic resistance is becoming a major concern in livestock and companion animals. The U.S. FDA reports increasing resistance in cattle, sheep, goats, horses, swine, and poultry, reducing the effectiveness of traditional dewormers. This trend is driving demand for new active ingredients, combination therapies, and resistance-monitoring programs to maintain parasite control and animal productivity.
Growth of Precision Parasite Management: Veterinarians are increasingly recommending targeted treatments instead of routine whole-herd deworming. FDA guidance highlights that blanket treatment can accelerate resistance development. Precision management uses fecal egg counts, diagnostic testing, and animal health monitoring to identify infected animals, improving treatment outcomes and reducing unnecessary antiparasitic usage.
Increased Demand for Tick and Vector Control: Vector-borne diseases continue to expand globally. According to the CDC, more than 1 million vector-borne disease cases were reported in the United States between 2001 and 2023. Growing tick and flea populations are increasing demand for long-lasting antiparasitic products for livestock and pets.
Development of Novel Antiparasitic Solutions: Regulatory agencies and researchers are emphasizing the need for new antiparasitic drugs, particularly for sheep and goats where resistance is widespread. Companies are investing in innovative formulations, improved delivery systems, and combination products to extend parasite control effectiveness.
Stronger Government and Industry Monitoring: Organizations such as the FDA and WOAH are promoting responsible antiparasitic use to preserve drug effectiveness. Global surveys conducted by WOAH identified resistance as a significant challenge across all regions, encouraging better surveillance, stewardship programs, and sustainable parasite-management practices.
Key Use Cases of Veterinary Antiparasitics
Parasite Control in Cattle Production: Antiparasitics are widely used in cattle to control internal worms, ticks, lice, and flies that reduce weight gain and milk production. Recent concerns over New World screwworm infestations in North America further highlight the importance of effective parasite management in protecting livestock health and preventing economic losses.
Sheep and Goat Health Management: Roundworm infections are a major challenge in sheep and goats. FDA data indicate growing resistance to existing treatments, creating a need for strategic deworming programs. Effective parasite control supports better growth rates, wool production, reproductive performance, and farm profitability.
Companion Animal Protection: Dogs and cats frequently require antiparasitic treatments to prevent fleas, ticks, mites, and heartworms. CDC information shows that vectors such as ticks and fleas can transmit diseases to pets, making preventive antiparasitic products an essential component of routine veterinary care.
Equine Parasite Management: Horse owners increasingly rely on evidence-based parasite control programs due to growing drug resistance. FDA initiatives encourage responsible use of antiparasitic products in horses, helping maintain animal health, performance, and welfare while slowing the development of resistant parasite populations.
Integrated Livestock Disease Prevention: Veterinary antiparasitics are increasingly used as part of broader herd-health strategies. External parasites can transmit diseases and affect animal welfare. Combining antiparasitic treatments with biosecurity, pasture management, and monitoring programs helps improve productivity and supports sustainable livestock production systems.
Conclusion: The global Veterinary Antiparasitics Market is poised for steady growth, expanding from US$ 6.9 billion in 2025 to US$ 14.2 billion by 2035 at a CAGR of 7.5%. Market expansion is being driven by rising pet ownership, increasing livestock production, growing awareness of animal health, and the need for effective parasite control. Companion animals remain the leading segment, while ectoparasiticides and oral formulations continue to dominate demand. Emerging trends such as precision parasite management, resistance monitoring, and development of innovative antiparasitic products are reshaping the industry. As parasite resistance becomes a critical challenge, sustainable treatment strategies, veterinary guidance, and advanced formulations will play a key role in supporting long-term animal health and market growth worldwide.
Top comments (0)